Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early insulin treatment in latent autoimmune diabetes in adults (LADA)
2006-004662-14Phase 4Terminated
- Sponsor
- Swansea Bay University Health Board
- Start
- Jan 2007
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of biphasic insulin aspart in latent autoimmune diabetes in adults (LADA) and diabetes mellitus (DM) (2 arms), sponsored by Swansea Bay University Health Board. Primary endpoint: Fasting serum C-peptide at 24 months. Started Jan 2007; status: terminated.
02
Drugs
biphasic insulin aspart
03
Conditions
latent autoimmune diabetes in adults (LADA)diabetes mellitus (DM)
Beyond the preview
Go deeper on 2006-004662-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004662-14.